Nkarta, Inc.
NKTX • NASDAQ
Nkarta, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Paul J. Hastings, with a market cap of $146.9M.
CEOPaul J. Hastings
Next Earnings
Upcoming earnings announcement for Nkarta, Inc.
Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.35
Earnings History
Past 12 earnings reports for Nkarta, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 25, 2026 | Q4 2025 | -$0.37Est: -$0.30 | -23.3% | - | — | — |
| Nov 10, 2025 | Q3 2025 | -$0.29Est: -$0.31 | +6.5% | - | — |  10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.31Est: -$0.36 | +13.9% | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.43Est: -$0.45 | +4.4% | - | — | 10-Q |
| Mar 26, 2025 | Q4 2024 | -$0.35Est: -$0.40 | +12.5% | - | — | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.39Est: -$0.36 | -8.3% | - | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$0.34Est: -$0.47 | +27.7% | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.58Est: -$0.60 | +3.3% | - | — | 10-Q |
| Mar 21, 2024 | Q4 2023 | -$0.57Est: -$0.59 | +3.4% | - | — | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.52Est: -$0.73 | +28.8% | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$0.68Est: -$0.68 | 0.0% | - | — | 10-Q |
| May 11, 2023 | Q1 2023 | $0.63Est: -$0.70 | +190.0% | - | — | 10-Q |